(Q57820051)

10

0 references

Alessandro Zerbi

1

object named as

Alessandro Zerbi

1 reference

Europe PubMed Central

PubMed publication ID

20857140

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20857140

17 July 2024

author name string

Vanessa Capitanio

3

0 references

Letizia Boninsegna

4

0 references

Claudio Pasquali

5

0 references

Gianfranco Delle Fave

7

0 references

Marco Del Chiaro

8

0 references

Riccardo Casadei

9

0 references

AISP Network Study Group

10

1 reference

Europe PubMed Central

PubMed publication ID

20857140

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20857140

full work available at URL

17 July 2024

language of work or name

English

0 references

publication date

21 September 2010

0 references

http://link.springer.com/content/pdf/10.1007/s00423-010-0712-4.pdf

file format

Portable Document Format

1 reference

DOI

https://api.crossref.org/works/10.1007/S00423-010-0712-4

http://link.springer.com/article/10.1007/s00423-010-0712-4/fulltext.html

17 July 2024

1 reference

https://api.crossref.org/works/10.1007/S00423-010-0712-4

http://link.springer.com/content/pdf/10.1007/s00423-010-0712-4

17 July 2024

1 reference

DOI

https://api.crossref.org/works/10.1007/S00423-010-0712-4

Langenbeck's Archives of Surgery

17 July 2024

published in

0 references

volume

396

0 references

issue

3

0 references

page(s)

313-321

0 references

cites work

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: chemotherapy in patients with neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Peptide receptor therapies in neuroendocrine tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Neuroendocrine tumors: role of interventional radiology in therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Resection of pancreatic neuroendocrine tumors: results of 70 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Malignant insulinoma: spectrum of unusual clinical features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Incidence and management of malignant digestive endocrine tumours in a well defined French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Surgery on neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Laparoscopic pancreatic resection: results of a multicenter European study of 127 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

21 January 2018

Neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Surgery for primary pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Well-differentiated pancreatic nonfunctioning tumors/carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Middle pancreatectomy: indications, short- and long-term operative outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Nonstandard pancreatic resections for unusual lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Surgical Treatment of Benign and Borderline Neoplasms of the Pancreatic Body

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00423-010-0712-4

Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?

21 January 2018

1 reference

12 December 2020

Effect of hospital volume on outcome of pancreaticoduodenectomy in Italy

1 reference

12 December 2020

Nonfunctioning islet cell carcinoma of the pancreas

1 reference

12 December 2020

Neuroendocrine pancreatic tumors. Clinical findings in a prospective study of 84 patients

1 reference

12 December 2020

Chemotherapy and biotherapy in the treatment of neuroendocrine tumours

1 reference

12 December 2020

Insulinoma: 31 years of tumor localization and excision

1 reference

12 December 2020

Clinicopathological Features of Pancreatic Endocrine Tumors: A Prospective Multicenter Study in Italy of 297 Sporadic Cases

1 reference

12 December 2020

Management of neuroendocrine tumours

1 reference

12 December 2020

Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors

1 reference

12 December 2020

Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patients

1 reference

12 December 2020

Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience

1 reference

12 December 2020

Identifiers

DOI